AVDL - Avadel Pharmace Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 ARRY (-0.78%) SPY (-0.09%) XLMUSD (%) WSM (0.34%) WKHS (8.19%) VXX (-2.69%) UPST (1.22%) TLRY (3.17%) SQQQ (-0.79%) SQ (1.75%) POSH (7.15%) KOLD (6.09%) JUPW (4.52%) IBM (-0.58%) GSAT (2.95%) FUBO (7.99%) CURI (3.58%) BTCUSD (%) BOSC (0.17%) BCHUSD (%)

AVDL - Avadel Pharmaceutica...

$7.41 0.18[2.49%]

15 mins delayed data

People also watch : EGRX | DRRX | HRTX | ALKS | TEVA | NKTR

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$7.23	Open	$7.23
Volume	141.2K	Market Cap	448.6M
Yield		Last Dividend

Day

52 Week

Avadel's Formulated Sodium Oxybate Shows...	04/19/21
Avadel Pharmaceuticals Plc (NASDAQ: AVDL ) has announced the presentation of secondary endpoint data from the Phase 3 REST-ON trial evaluating FT218 o...

Avadel Pharmaceuticals : Announces FDA A...	03/01/21
DUBLIN, Ireland, March 01, 2021 -- Avadel Pharmaceuticals plc today announced that the U.S. Food and Drug Administration has accepted for review the C...

Avadel Pharmaceuticals Announces Submiss...	12/16/20
DUBLIN, Ireland, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) today announced the submission of its New Drug Applicatio...

Avadel Pharmaceuticals : Added to NASDAQ...	12/15/20
DUBLIN, Ireland, Dec. 15, 2020 -- Avadel Pharmaceuticals plc , a company focused on developing FT218, an investigational, once-nightly formulation of ...

Avadel Pharmaceuticals (NASDAQ:AVDL) Low...	10/25/20
Avadel Pharmaceuticals (NASDAQ:AVDL) was downgraded by research analysts at BidaskClub from a ???sell??? rating to a ???strong sell??? rating in a res...

Avadel Pharmaceuticals (NASDAQ:AVDL) Sto...	10/24/20
Avadel Pharmaceuticals (NASDAQ:AVDL) was downgraded by analysts at BidaskClub from a ???sell??? rating to a ???strong sell??? rating in a research rep...

Avadel Pharmaceuticals (NASDAQ:AVDL) Dow...	10/24/20
BidaskClub cut shares of Avadel Pharmaceuticals (NASDAQ:AVDL) from a sell rating to a strong sell rating in a report issued on Friday morning, BidAskC...

Avadel Pharmaceuticals plc to Post FY202...	10/23/20
Avadel Pharmaceuticals plc (NASDAQ:AVDL) ??? SVB Leerink decreased their FY2022 earnings estimates for Avadel Pharmaceuticals in a report issued on Tu...

FY2022 EPS Estimates for Avadel Pharmace...	10/22/20
Avadel Pharmaceuticals plc (NASDAQ:AVDL) ??? Equities research analysts at SVB Leerink lowered their FY2022 earnings per share estimates for shares of...

North America Psychedelic Drugs Market 2...	10/07/20
To prepare this Psychedelic Drugs Market research report, an array of objectives of market research has been considered. While formulating this market...

Avadel Pharmaceuticals to Report Second ...	07/27/20
DUBLIN, Ireland, July 27, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced today that it will host a conference call and l...

Avadel Pharmaceuticals Announces First P...	07/13/20
Clinical study to enroll 250 patients from sites that participated in the REST-ON studyStudy to examine the long-term safety and maintenance of effica...

Avadel sells hospital sterile injectable...	07/01/20
Avadel Pharmaceuticals (AVDL -1.4%) sold its portfolio of sterile injectable drugs used in the hospital setting, including three commercial products, ...

How Avadel (AVDL) Stock Stands Out in a ...	06/01/20
Avadel (AVDL) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

ANALYST RATINGS

1 analyst ratings (Last 3 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Buy rating	03/10/21
HC Wainwright & Co. maintains Buy rating and raises Price Target from $15.00 to $17.00

EARNINGS

Date	2021-03-09 (BMO)	Est. (EPS/Rev.)	($0.27)/ 0
Actual (EPS/Rev.)	$-0.19/	EPS (TTM)	0

TRADERS TRACKING $AVDL

Service Name	Trader	% Success
TopFlight Trades - Short Plays	Eric Cunningham	40.00 %	Follow
Biotechnology	Robert Gadimian	26.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.